| | |
| Clinical data | |
|---|---|
| ATC code |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C15H12N4O3 |
| Molar mass | 296.286 g·mol−1 |
| |
| (verify) | |
CP-1414S is an experimental drug first made by a team in Germany. [1] It is a benzodiazepine derivative. CP-1414S is a 1,5-benzodiazepine, with the nitrogen atoms located at positions 1 and 5 of the diazepine ring, and so is most closely related to other 1,5-benzodiazepines such as clobazam.
CP-1414S has primarily anxiolytic and anticonvulsant effects. [2] Its potency is roughly equal to that of clobazam, but with more pronounced sedation. [3]